As of 4:00pm ET
| -0.15 / -1.68%|
The 2 analysts offering 12-month price forecasts for Oramed Pharmaceuticals Inc have a median target of 21.00, with a high estimate of 25.00 and a low estimate of 17.00. The median estimate represents a +139.45% increase from the last price of 8.77.
The current consensus among 2 polled investment analysts is to Buy stock in Oramed Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.